{
    "data": [
        {
            "id": "data_1",
            "omics": "Genomics",
            "link": "https://www.biosino.org/node/project/detail/OEP003191",
            "format": "matrix format",
            "source": "biosino NODE database",
            "public_id": "OEP003191-WES"
        },
        {
            "id": "data_2",
            "omics": "Epigenomics",
            "link": "https://www.biosino.org/node/project/detail/OEP003191",
            "format": "matrix format",
            "source": "biosino NODE database",
            "public_id": "OEP003191-RRBS"
        },
        {
            "id": "data_3",
            "omics": "Transcriptomics",
            "link": "https://www.biosino.org/node/project/detail/OEP003191",
            "format": "matrix format",
            "source": "biosino NODE database",
            "public_id": "OEP003191-RNAseq"
        },
        {
            "id": "data_4",
            "omics": "Proteomics",
            "link": "https://www.biosino.org/node/project/detail/OEP003191",
            "format": "matrix format",
            "source": "biosino NODE database",
            "public_id": "OEP003191-Proteomics"
        },
        {
            "id": "data_5",
            "omics": "Phosphoproteomics",
            "link": "https://www.biosino.org/node/project/detail/OEP003191",
            "format": "matrix format",
            "source": "biosino NODE database",
            "public_id": "OEP003191-Phosphoproteomics"
        },
        {
            "id": "data_6",
            "omics": "Metabolomics",
            "link": "https://www.biosino.org/node/project/detail/OEP003191",
            "format": "matrix format",
            "source": "biosino NODE database",
            "public_id": "OEP003191-Metabolomics"
        },
        {
            "id": "data_7",
            "omics": "Resource Portal",
            "link": "http://cancerdiversity.asia/LICOB/",
            "format": "interactive web portal",
            "source": "custom-built portal",
            "public_id": ""
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Consensus Clustering",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3",
                "data_4",
                "data_5"
            ],
            "label": {
                "cluster": [
                    "L-ICC (ICCOs)",
                    "L-PL (HCCOs)",
                    "L-LM (HCCOs)",
                    "L-DM (HCCOs)"
                ]
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "ssGSEA",
            "analysis_data": [
                "data_3",
                "data_4"
            ],
            "label": {
                "cluster": [
                    "L-ICC",
                    "L-PL",
                    "L-LM",
                    "L-DM"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Differential Protein Expression Analysis",
            "analysis_data": [
                "data_4"
            ],
            "label": {
                "cluster": [
                    "L-DM"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Elastic Net Regression for Regorafenib",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4"
            ],
            "label": null
        },
        {
            "id": "analysis_5",
            "analysis_name": "High-Throughput Drug Screening",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3",
                "data_4",
                "data_5"
            ],
            "label": null
        },
        {
            "id": "analysis_6",
            "analysis_name": "Network-Based Drug Combination Prediction",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4",
                "data_5"
            ],
            "label": null
        },
        {
            "id": "analysis_7",
            "analysis_name": "Comparison with LIMORE Cohort",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4"
            ],
            "label": null
        },
        {
            "id": "analysis_8",
            "analysis_name": "Survival Analysis of CPTAC Patients",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4"
            ],
            "label": {
                "cohort": "CPTAC"
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "Elastic Net Regression for Sorafenib",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4"
            ],
            "label": null
        },
        {
            "id": "analysis_10",
            "analysis_name": "Gene Set Enrichment Analysis (GSEA)",
            "analysis_data": [
                "data_3",
                "data_4"
            ],
            "label": {
                "cluster": [
                    "L-DM",
                    "L-PL",
                    "L-LM"
                ]
            }
        },
        {
            "id": "analysis_11",
            "analysis_name": "Elastic Net Regression for Lenvatinib",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4",
                "data_5"
            ],
            "label": null
        },
        {
            "id": "analysis_12",
            "analysis_name": "Principal Component Analysis (PCA) for Subtype Validation",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4",
                "data_5"
            ],
            "label": null
        },
        {
            "id": "analysis_13",
            "analysis_name": "Pathway-Level Proteomic Comparison with CPTAC ICC Tissues",
            "analysis_data": [
                "data_4"
            ],
            "label": {
                "cluster": [
                    "S-ICCOs",
                    "R-ICCOs"
                ]
            }
        },
        {
            "id": "analysis_14",
            "analysis_name": "Validation of Drug Combinations",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4",
                "data_5"
            ],
            "label": null
        },
        {
            "id": "analysis_15",
            "analysis_name": "Mechanistic Pathway Analysis of MYC-NRF2-G6PD Axis",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4"
            ],
            "label": {
                "cluster": [
                    "L-DM"
                ]
            }
        },
        {
            "id": "analysis_16",
            "analysis_name": "Comparison with TCGA and CPTAC Cohorts",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4"
            ],
            "label": null
        },
        {
            "id": "analysis_17",
            "analysis_name": "GDSC Validation for Sorafenib",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4"
            ],
            "label": null
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": null,
            "value": null,
            "features": [
                "L-ICC (ICCOs)",
                "L-PL (HCCOs)",
                "L-LM (HCCOs)",
                "L-DM (HCCOs)"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": null,
            "value": null,
            "features": [
                "RAS signaling",
                "cell junction",
                "cell cycle",
                "MAPK pathways",
                "lipid metabolism",
                "drug metabolism"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": null,
            "value": null,
            "features": [
                "G6PD"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Pearson's correlation coefficient",
            "value": "0.78",
            "features": [
                "AMPK activation",
                "autophagy",
                "MYC amplification",
                "NRF2 expression",
                "G6PD expression",
                "MYEOV hypermethylation"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "AUC, IC50, Emax",
            "value": "Higher AUC for lenvatinib-resistant organoids, varied IC50 and Emax values for 76 drugs",
            "features": [
                "HBV status",
                "TP53 mutation",
                "CTNNB1 mutation",
                "KRAS mutation",
                "BAP1 mutation",
                "VEGF pathway",
                "ADH1C protein level",
                "CES1 protein level"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": null,
            "value": null,
            "features": [
                "lenvatinib + temsirolimus",
                "lenvatinib + ganetespib"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": null,
            "value": null,
            "features": [
                "L-PL vs LIMORE proliferation dominance",
                "L-LM/L-DM metabolic features"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "overall survival",
            "value": "L-PL had worst survival, L-LM best survival",
            "features": [
                "TCGA/CPTAC molecular subtypes",
                "proteogenomic clustering"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "Pearson's correlation coefficient",
            "value": "0.69",
            "features": [
                "IGF1/IGF1R pathway",
                "tyrosine and intracellular kinase pathways",
                "HDAC pathway",
                "endocytosis",
                "decreased IGF1R protein level"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "GO Enrichment Score",
            "value": null,
            "features": [
                "Reactome Glycolysis",
                "KEGG Lipid Metabolism",
                "Cell Cycle Mitotic",
                "Drug Metabolism"
            ]
        },
        {
            "analysis_id": "analysis_11",
            "metrics": "Pearson's correlation coefficient",
            "value": "0.68",
            "features": [
                "thromboxane pathway",
                "VEGF pathway",
                "KRT19 mRNA expression",
                "NDN mRNA expression"
            ]
        },
        {
            "analysis_id": "analysis_12",
            "metrics": "PCA clustering",
            "value": null,
            "features": [
                "L-LM and L-PL defined by PC1",
                "L-DM distinguished by PC2 + PC3"
            ]
        },
        {
            "analysis_id": "analysis_13",
            "metrics": "pathway similarity",
            "value": "R-ICCOs close to CPTAC poor survival subtype (S1)",
            "features": [
                "EGFR-TKI-resistant features",
                "TP53 mutation",
                "KRAS mutation",
                "ERBB2 amplification",
                "MAP3K3 amplification",
                "PTPN11 expression",
                "MAP3K2 expression",
                "interferon signaling"
            ]
        },
        {
            "analysis_id": "analysis_14",
            "metrics": "p-value from Two-way ANOVA and Log-rank test",
            "value": "Significant inhibition in HCCO31 xenograft and lenvatinib-resistant PDX models",
            "features": [
                "MEK/ERK pathway inhibition",
                "AKT activation reversal",
                "EGFR inhibitor resistance",
                "TGF-beta signaling",
                "23,754 quantified phosphosites"
            ]
        },
        {
            "analysis_id": "analysis_15",
            "metrics": null,
            "value": null,
            "features": [
                "MYC amplification",
                "NRF2 expression",
                "G6PD expression",
                "PGD, TKT, TALDO1 upregulation",
                "NADPH/GSH production",
                "PPP flux",
                "redox homeostasis"
            ]
        },
        {
            "analysis_id": "analysis_16",
            "metrics": null,
            "value": null,
            "features": [
                "TCGA molecular subtypes",
                "CPTAC molecular subtypes",
                "proteogenomic clustering"
            ]
        },
        {
            "analysis_id": "analysis_17",
            "metrics": "Pearson's correlation coefficient",
            "value": "Validated in GDSC database",
            "features": [
                "sorafenib response",
                "HCC cell lines"
            ]
        }
    ]
}